In the HA-WBRT subgroup, a trend favoring ECT was observed, but it did not reach statistical significance for OS (HR 0.71, 95% CI 0.430–1.170; P = 0.177) or iPFS (HR 0.66, 95% CI 0.400–1.090; P = 0.103). 3.7 Treatment-related adverse events The safety profile of the ECT strategy was comparable to that of the SRT strategy.
← all excerpts
Early brain radiotherapy combined with third-generation EGFR-TKIs improves survival in EGFR-mutant NSCLC with synchronous brain metastases: a multi-center retrospective analysis.
1
0.1770
0.1770